DSM plans new production site for Bovaer® in Dalry, Scotland
HEERLEN, Netherlands, Nov. 9, 2021 /PRNewswire/ -- Royal DSM, a global purpose-led science-based company active in Health, Nutrition and Bioscience, announces today at COP26 in Glasgow that it is planning to realize large scale production capacity for its novel methane-reducing feed additive for ruminants, Bovaer® with a new plant at its existing site in Dalry, Scotland, supported by Scottish Enterprise. As emphasized by the First Minister of Scotland at the announcement, Scotland offers a welcoming and supportive environment for innovation and production, and is leading the way for a net zero future.
Reducing methane emissions is crucial to reach the Paris Agreement target of maximum 1.5 degree warming, especially since methane's warming effect is shorter lived and much more potent than carbon dioxide. Therefore eliminating methane will pay off right away. Experts at COP26 have emphasized the great impact additional focus on methane emission reduction can have, which was also expressed in the recently announced global pledge aiming at reducing methane emissions by 30% by 2030. Amongst other things, methane is emitted from cows – over 50% of emissions from milk production comes in the form of enteric methane emission. Bovaer® is a feed additive for cows which consistently reduces enteric methane emission by approximately 30% for ruminants. The endeavor to develop Bovaer® encompassed over 10 years, 45 on-farm trials in 13 countries across 4 continents, and more than 48 peer-reviewed studies published in independent scientific journals.
Early September 2021 DSM received full regulatory approvals in Brazil and Chile for its feed additive Bovaer®. DSM has available initial commercial product volumes for near term market development. To prepare for further scale up in the next years, engineering for a new large plant in Dalry has started, which is targeted to be started up in the course of 2025. DSM's Dalry manufacturing site has been in operation for over 60 years and produces high quality micro-nutrients. The site is the only Western producer of vitamin C.
Geraldine Matchett and Dimitri de Vreeze, co-CEOs of DSM commented: "First of all we are pleased with the Scottish government's support of the buildup of our production capacity of Bovaer®, particularly within the context of COP26, where the importance of fast climate action through reduction of methane emissions is emphasized again. We are looking forward offering a scientifically proven effective solution to the challenge of methane emissions by farming. As food systems and climate crisis are intrinsically linked, addressing the challenge of sustainable animal farming for a healthy planet is pivotal."
Nicola Sturgeon, First Minister of Scotland, said: "Methane reducing feed additives are a crucial part of the solutions that the agriculture sector needs to deploy towards achieving climate ambitions. This multi-million pound investment will make Scotland the home of this innovative product and highlights that Scotland is leading the way in delivering a net zero future."
Scottish Enterprise's Managing Director, Linda Hanna added: "Royal DSM's Project Bovaer® has the potential to be a gamechanger for the world's net zero ambitions and I am delighted that Scotland was chosen as the ideal location for this project. Alongside our partners, Scottish Enterprise worked closely with Royal DSM to build a strong relationship and provide support to help them choose Dalry as the target site for this global manufacturing opportunity. As we support sustainable economic recovery, this investment by Royal DSM provides a real boost for Scotland's economy. It also very much underlines the message we are sharing with the world: that Scotland is open for business."
DSM recently launched a series of new quantifiable commitments aimed to address urgent societal and environmental challenges linked to how the world produces and consumes food by 2030, the Food System Commitments. These commitments cover three areas where the company believes it can make the greatest positive impact together with its business partners: Health for People, Health for Planet and Healthy Livelihoods. One of DSM's commitments is to enable double-digit on-farm reduction of livestock emissions by 2030. DSM can help make a sizeable reduction in emissions from farms by changing the feed that animals eat every day. Bovaer® is a prime example: one quarter of a teaspoon per cow per day will consistently reduce enteric methane emission by approximately 30% - enabling a 10-12% reduction in greenhouse gas emissions per kilo of milk.
DSM
Royal DSM is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. DSM's purpose is to create brighter lives for all. DSM's products and solutions address some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM and its associated companies employ approximately 23,000 people around the world and deliver annual net sales of about €10 billion. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
Or find us on:
Facebook: http://www.facebook.com/DSMcompany
Twitter: http://www.twitter.com/DSM
LinkedIn: http://www.linkedin.com/company/3108
YouTube: http://www.youtube.com/user/dsmcompany
About Bovaer®
Bovaer® is a feed additive for cows researched and developed over 10 years by DSM. Just a quarter teaspoon of Bovaer® per cow per day consistently reduces enteric methane emission by approximately 30% for dairy cows and even higher percentages (up till 90%) for beef cows. The feed additive Bovaer® therefore contributes to a significant and immediate reduction of the environmental footprint of meat, milk and dairy products. Bovaer® is the most extensively studied and scientifically proven solution to the challenge of burped methane to date. Upon feeding, It takes effect immediately.
About DSM in Dalry
DSM Nutritional Products (UK) Ltd, is one of the region's most prominent companies, employing over 300 staff and around 150 to 200 contractors at the Dalry production facility situated in North Ayrshire, 25 miles south-west of Glasgow. The site has been producing vitamins since 1958 and today the main production processes are Vitamin C, Calcium-D-Pantothenate (vitamin B5) and Panthenol (proVitamin B5).
All our vitamin forms produced at the Dalry facility serve the highly varied needs of the human and animal nutrition and health sectors, as well as the pharmaceutical industry and personal care industries.
The Dalry site is fully committed to sustainability for the future. We have delivered significant investment to demonstrate continued reduction of our CO2 emissions, which has focused on technology improvements within our production processes and utilities operations. This work continues to identify further continuous improvement activity alongside development of step change opportunities.
For more information:
DSM Media relations Andre van der Elsen tel. +31 (0) 45 5782421 email media.contacts@dsm.com |
DSM Investor Relations Dave Huizing tel. +31 (0) 45 5782864 |
Forward-looking statements
This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
Logo - https://mma.prnewswire.com/media/329419/dsm_logo.jpg
The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.
